Of 15 analysts covering Cardinal Health stock, 11 rate Cardinal as a Hold and three have a Buy or Strong Buy rating. At a recent price of around $76.20 a share, the stock has outrun its median price target of $72.00. At the high target of $78.00, the upside potential is 2.3%.
First-quarter revenue for fiscal 2023 is expected to come in at $48.16 billion, which would be up 2.2% sequentially and 9.5% higher year over year. Adjusted EPS are forecast at $0.97, down 7.3% sequentially and by 24.8% year over year. For the full fiscal year ending next September, estimates call for EPS of $5.25, up about 3.8%, on sales of $198.06 billion, up 9.2%.
Cardinal stock trades at about 14.5 times expected 2023 EPS, 12.4 times estimated 2024 earnings of $6.16 and 10.5 times estimated 2025 earnings of $7.23 per share. The stock’s 52-week trading range is $45.85 to $77.19. The company pays an annual dividend of $1.98 (yield of 2.57%), and the total shareholder return for the past 12 months was 61.65%.
DraftKings
Online sports betting and gambling company DraftKings Inc. (NASDAQ: DKNG) has seen its share price decline by 65% over the past 12 months. Shares put up their high exactly one year ago and dropped to their annual low in mid-May, down 95%. Since then, the stock is up about 45%. Spending on marketing has increased, and investors are hoping that a strong NFL betting handle will boost revenue and profits. Mobile betting is rising, as are parlay bets, which pay off significantly better for the house.
Analysts remain somewhat bullish on the stock, with 16 of 30 having a Buy or Strong Buy rating. Thirteen have a Hold rating on the shares. At a price of around $16.65 a share, the upside potential based on a median price target of $24.50 is 47.1%. At the high target of $52.00, the upside potential is about 212%.
Third-quarter revenue is forecast at $437.02 million, down 6.2% sequentially bug up about 105% year over year. Analysts are forecasting a loss per share of $0.94 in the quarter, compared to a prior-quarter loss of $0.49 and a year-ago loss of $1.35 per share. For the full 2022 fiscal year, DraftKings is expected to post a per-share loss of $2.51, better than the $3.69 loss per share in 2021. Sales are forecast to rise 65% year over year to $2.14 billion.
DraftKings is not expected to post a profit in 2022, 2023 or 2024. Its stock trades at a multiple of 3.4 times estimated 2022 enterprise value to sales, 2.6 times estimated 2023 EV to sales and 2.1 times estimated 2024 EV to sales. The stock’s 52-week range is $9.77 to $48.17. The company does not pay a dividend. The total shareholder return for the past year was negative 64.8%.
Originally published at 24/7 Wall St.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
